139Scadden DT (2006) The stem-cell niche as an entity of action. Nature 441(7097):1075–1079
Scheres B (2007) Stem-cell niches: nursery rhymes across kingdoms. Nat Rev Mol Cell Biol
8(5):345–354
Seidel S, Garvalov BK, Wirta V et al (2010) A hypoxic niche regulates glioblastoma stem cells
through hypoxia inducible factor 2 alpha. Brain 133(Pt 4):983–995
Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and thera-
peutics. Oncogene 29(5):625–634
Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic
mutations. J Clin Invest 123(9):3664–3671
Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem
cells versus clonal evolution. Cell 138(5):822–829
Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain
tumors. Cancer Res 63(18):5821–5828
Singh SK, Hawkins C, Clarke ID et al (2004a) Identification of human brain tumour initiating
cells. Nature 432
Singh SK, Clarke ID, Hide T, Dirks PB (2004b) Cancer stem cells in nervous system tumors.
Oncogene 23(43):7267–7273
Soda Y, Marumoto T, Friedmann-Morvinski D et al (2011) Transdifferentiation of glioblastoma
cells into vascular endothelial cells. Proc Natl Acad Sci U S A 108(11):4274–4280
Son MJ, Woolard K, Nam DH, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-
initiating cells in human glioblastoma. Cell Stem Cell 4(5):440–452
Sottoriva A, Spiteri I, Piccirillo SGM et al (2013) Intratumor heterogeneity in human glioblastoma
reflects cancer evolutionary dynamics. Proc Natl Acad Sci 110(10):4009–4014
Stier S, Ko Y, Forkert R et al (2005) Osteopontin is a hematopoietic stem cell niche component that
negatively regulates stem cell pool size. J Exp Med 201(11):1781–1791
Stockhausen M-T, Kristoffersen K, Poulsen HS (2009) The functional role of Notch signaling in
human gliomas. Neurooncology 12(2):199–211
Sun X, Cheng G, Hao M et al (2010) CXCL12/CXCR4/CXCR7 chemokine axis and cancer pro-
gression. Cancer Metastasis Rev 29(4):709–722
Tallet AV, Azria D, Barlesi F et al (2012) Neurocognitive function impairment after whole brain
radiotherapy for brain metastases: actual assessment. Radiat Oncol 7(1):77
Tan BT, Park CY, Ailles LE, Weissman IL (2006) The cancer stem cell hypothesis: a work in prog-
ress. Lab Investig 86(12):1203–1207
Tavazoie M, Van der Veken L, Silva-Vargas V et al (2008) A specialized vascular niche for adult
neural stem cells. Cell Stem Cell 3(3):279–288
Tomuleasa C, Soritau O, Rus-Ciuca D et al (2010) Isolation and characterization of hepatic can-
cer cells with stem-like properties from hepatocellular carcinoma. J Gastrointestin Liver Dis
19(1):61–67
Uchida N, Buck DW, He D et al (2000) Direct isolation of human central nervous system stem
cells. Proc Natl Acad Sci 97(26):14720–14725
Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL (1999) Vitronectin, a glioma-derived
extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res
5(6):1587–1594
Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new
advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin
60(3):166–193
Venneri MA, De Palma M, Ponzoni M et al (2007) Identification of proangiogenic TIE2-expressing
monocytes (TEMs) in human peripheral blood and cancer. Blood 109(12):5276–5285
Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically
relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR,
and NF1. Cancer Cell 17(1):98–110
Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6(6):425–436
7 Glioblastoma Stem Cells and Their Microenvironment